BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33495292)

  • 1. Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes.
    Meek CL; Tundidor D; Feig DS; Yamamoto JM; Scott EM; Ma DD; Halperin JA; Murphy HR; Corcoy R;
    Diabetes Care; 2021 Mar; 44(3):681-689. PubMed ID: 33495292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Glucose Monitoring Time-in-Range and HbA
    Tundidor D; Meek CL; Yamamoto J; Martínez-Bru C; Gich I; Feig DS; Murphy HR; Corcoy R;
    Diabetes Technol Ther; 2021 Oct; 23(10):710-714. PubMed ID: 33945304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pumps or Multiple Daily Injections in Pregnancy Involving Type 1 Diabetes: A Prespecified Analysis of the CONCEPTT Randomized Trial.
    Feig DS; Corcoy R; Donovan LE; Murphy KE; Barrett JFR; Sanchez JJ; Wysocki T; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Diabetes Care; 2018 Dec; 41(12):2471-2479. PubMed ID: 30327362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: A post-hoc analysis of the GlucoMOMS trial.
    Rademaker D; van der Wel AWT; van Eekelen R; Voormolen DN; de Valk HW; Evers IM; Mol BW; Franx A; Siegelaar SE; van Rijn BB; DeVries JH; Painter RC;
    Diabetes Obes Metab; 2023 Dec; 25(12):3798-3806. PubMed ID: 37735847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes.
    McLean A; Barr E; Tabuai G; Murphy HR; Maple-Brown L
    Diabetes Technol Ther; 2023 Dec; 25(12):836-844. PubMed ID: 37902969
    [No Abstract]   [Full Text] [Related]  

  • 7. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters.
    Murphy HR
    Diabetologia; 2019 Jul; 62(7):1123-1128. PubMed ID: 31161344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Continuous Glucose Monitoring Metrics With Pregnancy Outcomes in Patients With Preexisting Diabetes.
    Sanusi AA; Xue Y; McIlwraith C; Howard H; Brocato BE; Casey B; Szychowski JM; Battarbee AN
    Diabetes Care; 2024 Jan; 47(1):89-96. PubMed ID: 37782847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
    Desouza CV; Rosenstock J; Kohzuma T; Fonseca VA
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1193-e1198. PubMed ID: 37259605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated albumin and continuous glucose monitoring metrics across pregnancy in women with pre-gestational diabetes.
    Toft JH; Dalen I; Skadberg Ø; Gøransson LG; Økland I; Bleskestad IH
    Endocrinol Diabetes Metab; 2022 Nov; 5(6):e376. PubMed ID: 36121204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women With Type 1 Diabetes.
    Ling P; Yang D; Gu N; Xiao X; Lu J; Liu F; Zhou Z; Huang Q; Zhao J; Zhang M; Hu J; Luo S; Weng J; Yan J; Zheng X
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4309-e4317. PubMed ID: 34244734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes.
    Sibiak R; Gutaj P; Mrzewka-Rogacz B; Mantaj U; Wender-Ozegowska E
    Diabetes Technol Ther; 2022 Jan; 24(1):42-53. PubMed ID: 34524000
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes.
    Scott EM; Feig DS; Murphy HR; Law GR;
    Diabetes Care; 2020 Jun; 43(6):1178-1184. PubMed ID: 32209645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of continuous glucose monitoring compared with self-monitoring of blood glucose in gestational diabetes patients with HbA1c<6%: a randomized controlled trial.
    Lai M; Weng J; Yang J; Gong Y; Fang F; Li N; Kang M; Xu X; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1174239. PubMed ID: 37152928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Feasibility Study of Paired Continuous Glucose Monitoring Intrapartum and in the Newborn in Pregnancies Complicated by Type 1 Diabetes.
    Stewart ZA; Thomson L; Murphy HR; Beardsall K
    Diabetes Technol Ther; 2019 Jan; 21(1):20-27. PubMed ID: 30620640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous glucose monitoring parameters in pregnancy-related complications in patients with type 1 diabetes: a retrospective cohort study.
    Sibiak R; Mantaj U; Gutaj P; Zozulińska-Ziółkiewicz D; Wender-Ozegowska E
    Pol Arch Intern Med; 2023 Nov; 133(11):. PubMed ID: 37227218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Glucose Monitoring and Time in Range: Association with Adverse Outcomes among People with Type 2 or Gestational Diabetes Mellitus.
    Bitar G; Cornthwaite JA; Sadek S; Ghorayeb T; Daye N; Nazeer S; Ghafir D; Cornthwaite J; Chauhan SP; Sibai BM; Fishel Bartal M
    Am J Perinatol; 2024 May; 41(S 01):e1370-e1377. PubMed ID: 36858069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.